Product
SU011248
1 clinical trial
3 indications
Indication
Von Hippel-Lindau SyndromeIndication
Renal Cell CarcinomaIndication
HemangioblastomaClinical trial
A Phase 2 Study of SU011248 (Sunitinib Malate) in Von Hippel-Lindau SyndromeStatus: Terminated, Estimated PCD: 2011-05-01